BALTIMORE, MD—February 5, 2014—Endocrine Society and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), are pleased to present a new audio-enhanced, CME-certified online publication for endocrinologists, Contemporary Updates and Expert Insights in Hypoparathyroidism.This interactive publication reviews the pathophysiology of hypoparathyroidism and explores strategies for recognizing the patient impact and long-term complications related to this rare endocrine disorder. It also discusses methods for identifying symptoms associated with hypoparathyroidism, as well as appropriate diagnostic tests and current and emerging treatment options.
This interactive publication reviews the pathophysiology of hypoparathyroidism and explores strategies for recognizing the patient impact and long-term complications related to this rare endocrine disorder. It also discusses methods for identifying symptoms associated with hypoparathyroidism, as well as appropriate diagnostic tests and current and emerging treatment options.”Recent advances in the diagnosis and treatment of hypoparathyroidism have the potential to be practice game
Recent advances in the diagnosis and treatment of hypoparathyroidism have the potential to be practice game changers.”
said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ.
“This initiative is designed to provide endocrinologists an overview of evidence-based practices to help enhance the care of patients with this condition. Through Web-enabled audio clips, Drs. Bilezikian and Clarke provide their expert perspectives on practical issues regarding state-of-the-art patient care, including the role of parathyroid hormone agents currently in clinical development.”
John P. Bilezikian, MD
Professor of Medicine
Chief, Division of Endocrinology
Director, Metabolic Bone Diseases Program
College of Physicians and Surgeons
Division of Endocrinology
New York, NY
Bart L. Clarke, MD
Associate Professor of Medicine
College of Medicine, Mayo Clinic
Consultant and Chair, Metabolic Bone Disease Core Group
Mayo Clinic Division of Endocrinology, Diabetes, Metabolism and Nutrition
This activity was developed through a collaboration between Endocrine Society and Med-IQ.
This activity is approved for AMA PRA Category 1 Credit™.
This activity is supported by an educational grant from NPS Pharmaceuticals, Inc.
© 2013 Endocrine Society. All rights reserved.
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award (2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
Catherine B. Mullaney, MHA
Vice President, Educational Partnerships
866 858 7434
Inspiring Medical Education.